ROMEO PUZON: Open Payments
NPI 1538190608 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,675 in 43 payments from 15 companies in 2025. Trend: 2023 $1,597 · 2024 $1,695 · 2025 $1,675
Food & beverage: $1,675
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $397 |
| AstraZeneca Pharmaceuticals LP | 7 | $279 |
| Amgen Inc. | 5 | $216 |
| Braeburn Inc. | 4 | $174 |
| Lilly USA, LLC | 6 | $144 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 2 | $59 |
| Exact Sciences Corporation | 2 | $58 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
Products named: AIRSUPRA, LINZESS, BRIXADI, BIJUVA, CREON, MOUNJARO, OTEZLA, Repatha.
Industry payments across WA — which companies pay providers there.
